A Comprehensive Map of FDA-Approved Pharmaceutical Products
With the increasing research and development (R&D) difficulty of new molecular entities (NMEs), novel drug delivery systems (DDSs) are attracting widespread attention. This review investigated the current distribution of Food and Drug Administration (FDA)-approved pharmaceutical products and eva...
Saved in:
Main Authors: | Hao Zhong (Author), Ging Chan (Author), Yuanjia Hu (Author), Hao Hu (Author), Defang Ouyang (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2018-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Academic Career Progression of Chinese-Origin Pharmacy Faculty Members in Western Countries
by: Weixiang Zhang, et al.
Published: (2018) -
Internationalization of traditional Chinese medicine: current international market, internationalization challenges and prospective suggestions
by: Annie Xianghong Lin, et al.
Published: (2018) -
A Comprehensive Review of Clinical Cardiotoxicity Incidence of FDA-Approved Small-Molecule Kinase Inhibitors
by: Ying Jin, et al.
Published: (2020) -
Selumetinib-A Comprehensive Review of the New FDA-Approved Drug for Neurofibromatosis
by: Surajit Gorai, et al.
Published: (2024) -
The Latest FDA-Approved Pharmaceuticals Containing Fragments of Tailor-Made Amino Acids and Fluorine
by: Qian Wang, et al.
Published: (2022)